Cilamin-250 (Penicillamine Tablet) 250

Cilamin-250 (Penicillamine 250 mg) is a chelating agent used to manage conditions like Wilson’s disease and cystinuria. This 50-tablet pack supports long-term therapy with ambient storage. Penicillamine 250 mg tablets are prescribed for specific metal overload disorders.

Strength

250

Pack Size

5 x 10 cap

Storage

Ambient

Manufacturer / TM Owner

Panacea Biotech

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Penicillamine 250 mg tablets are primarily used to reduce excess copper in Wilson’s disease, a genetic disorder causing copper buildup. They also help prevent kidney stones in cystinuria by lowering cystine levels. This medication is sometimes prescribed for rheumatoid arthritis when other treatments are ineffective. Always use as directed by a healthcare professional.

Side Effects

Cilamin-250 works by binding to excess metals or amino acids in the body, helping the kidneys remove them through urine. Users may notice improved symptoms related to copper overload or kidney stone prevention over time. Effects vary by individual and condition being treated.

Precautions & Warnings

Store Cilamin-250 at room temperature away from moisture and heat. Keep out of reach of children and pets. Regular blood and urine tests may be needed to monitor safety and effectiveness. Report any unusual symptoms like rash or fever immediately to a healthcare provider.

Avoid Interactions

Penicillamine may interact with iron supplements, antacids, or certain arthritis medications. Avoid taking these within 2 hours of each other to reduce interference. Alcohol and other drugs metabolized by the liver may alter effects; consult a doctor before combining therapies.

References

Frequently Asked Questions

Cilamin-250 is used to treat Wilson’s disease by reducing excess copper and to prevent kidney stones in cystinuria.

Store at room temperature in a dry place, away from direct light and out of reach of children.

It may be taken with or without food, but consistency in timing helps maintain steady levels in the body.

Common effects may include nausea, loss of taste, or skin rash; report persistent issues to a healthcare provider.

Consult a doctor before use; this medication may not be recommended during pregnancy due to potential risks.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.